PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer

N Engl J Med. 2023 Aug 31;389(9):866-867. doi: 10.1056/NEJMc2308037.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • B7-H1 Antigen
  • Endometrial Neoplasms* / drug therapy
  • Female
  • Humans
  • Programmed Cell Death 1 Receptor*

Substances

  • pembrolizumab
  • Programmed Cell Death 1 Receptor
  • B7-H1 Antigen
  • Antibodies, Monoclonal, Humanized